Healthcare provider profile · identity verified

Andrew Beine, MD

Family Practice · CHILTON, WI · NPI 1194256040

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	514	136
Eliquis	Apixaban	412	52
Furosemide	Furosemide	408	70
Amlodipine Besylate	Amlodipine Besylate	371	90
Levothyroxine Sodium	Levothyroxine Sodium	298	50
Lisinopril	Lisinopril	288	82
Gabapentin	Gabapentin	283	56
Losartan Potassium	Losartan Potassium	281	73
Metoprolol Succinate	Metoprolol Succinate	256	59
Pantoprazole Sodium	Pantoprazole Sodium	201	54
Potassium Chloride	Potassium Chloride	192	45
Hydrochlorothiazide	Hydrochlorothiazide	171	41
Spironolactone	Spironolactone	164	31
Omeprazole	Omeprazole	159	45
Simvastatin	Simvastatin	147	35
Metoprolol Tartrate	Metoprolol Tartrate	135	34
Metformin Hcl	Metformin Hcl	112	29
Duloxetine Hcl	Duloxetine Hcl	104	20
Mirtazapine	Mirtazapine	104	27
Sertraline Hcl	Sertraline Hcl	98	27
Escitalopram Oxalate	Escitalopram Oxalate	96	20
Trazodone Hcl	Trazodone Hcl	96	27
Metformin Hcl Er	Metformin Hcl	95	29
Glipizide Er	Glipizide	92	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	87	18
Allopurinol	Allopurinol	86	19
Fluoxetine Hcl	Fluoxetine Hcl	84	16
Tamsulosin Hcl	Tamsulosin Hcl	84	25
Pravastatin Sodium	Pravastatin Sodium	82	16
Albuterol Sulfate Hfa	Albuterol Sulfate	80	43
Jardiance	Empagliflozin	78	13
Xarelto	Rivaroxaban	78	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	69	23
Buspirone Hcl	Buspirone Hcl	66	17
Citalopram Hbr	Citalopram Hydrobromide	66	18
Ondansetron Hcl	Ondansetron Hcl	66	19
Cephalexin	Cephalexin	64	30
Prednisone	Prednisone	63	43
Pregabalin	Pregabalin	61	12
Atenolol	Atenolol	57	12
Levetiracetam	Levetiracetam	55	suppressed
Divalproex Sodium	Divalproex Sodium	53	suppressed
Ozempic	Semaglutide	53	suppressed
Clopidogrel	Clopidogrel Bisulfate	52	15
Fluticasone Propionate	Fluticasone Propionate	51	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	29
Donepezil Hcl	Donepezil Hcl	47	suppressed
Bupropion Xl	Bupropion Hcl	46	suppressed
Carvedilol	Carvedilol	46	13
Lamotrigine	Lamotrigine	46	suppressed
Glipizide	Glipizide	43	suppressed
Montelukast Sodium	Montelukast Sodium	39	13
Warfarin Sodium	Warfarin Sodium	37	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	13
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	26
Alendronate Sodium	Alendronate Sodium	35	suppressed
Bumetanide	Bumetanide	35	suppressed
Latanoprost	Latanoprost	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Risperidone	Risperidone	33	suppressed
Famotidine	Famotidine	32	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Terazosin Hcl	Terazosin Hcl	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Azithromycin	Azithromycin	28	26
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	28	11
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	12
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	27	suppressed
Solifenacin Succinate	Solifenacin Succinate	27	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	26	suppressed
Oxcarbazepine	Oxcarbazepine	25	suppressed
Baclofen	Baclofen	24	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Colchicine	Colchicine	22	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Breyna	Budesonide/Formoterol Fumarate	20	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	20	suppressed
Glatiramer Acetate	Glatiramer Acetate	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	16
Fluconazole	Fluconazole	19	17
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	18	18
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Finasteride	Finasteride	18	suppressed
Lorazepam	Lorazepam	18	11
Alprazolam	Alprazolam	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Savella	Milnacipran Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Cefdinir	Cefdinir	14	14
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Metolazone	Metolazone	13	suppressed
Nystatin	Nystatin	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Lactulose	Lactulose	12	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Nystop	Nystatin	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error